1. Pharmaceutical compositions for transdermal administration of a monophasic water-alcohol type with an amount of alcohol of more than 30%, containing a steroid hormone associated with at least one fatty acid and propylene glycol ester as a penetrating agent. ! 2. The pharmaceutical compositions for transdermal administration according to claim 1, characterized in that they contain N, N-diethyl-m-toluamide, or DEET, as a non-polar solvent in the aqueous-alcohol phase in a concentration of from 0.1 to 0.5 % (mass / mass) of the composition. ! 3. The pharmaceutical compositions for transdermal administration according to claim 1, characterized in that they are in the form of gels or solutions containing testosterone as a steroid hormone with a concentration of from 0.1% to 5% (weight / weight) of the composition. ! 4. The pharmaceutical compositions for transdermal administration according to claim 1, characterized in that they contain at least one gelling agent, such as carbomer. ! 5. The pharmaceutical compositions for percutaneous administration according to claim 1, characterized in that the concentration of the fatty acid ester and propylene glycol ranges from 0.5% to 10% (weight / weight) of the composition. ! 6. The pharmaceutical compositions for transdermal administration according to claim 1, characterized in that they contain 2.5% (w / w) propylene glycol monolaurate. ! 7. The pharmaceutical compositions for transdermal administration according to claim 1, characterized in that they contain 5% (mass / mass) of propylene glycol monocaprylate. ! 8. The pharmaceutical compositions for transdermal administration according to claim 1, characterized in that they contain a mixture of propylene glycol monolaurate and propylene glycol monocaprylate, preferably in equal weight. ! 9. Pharmaceutical com1. Фармацевтические композиции для чрескожного введения монофазного водно-спиртового типа с количеством спирта более 30%, содержащие стероидный гормон, связанный по мен
